Can white ginseng boost blood flow? new trial investigates

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women aged 20 to under 65 years * Platelet aggregation response above 55% (satisfied for both collagen and ADP) * Provides voluntary written informed consent to participate Exclusion Criteria: * History of hypersensitivity or allergy to ginseng-containing products that may affect the results * Surgery under general anesthesia within 12 weeks before participation * Use of contraindicated products such as red ginseng or omega-3 fatty acids within 2 weeks before screening * Use of antiplatelet drugs such as aspirin within 2 weeks before screening (subjects on prophylactic aspirin \<100 mg with unchanged dose/method may participate) * Uncontrolled hypertension not managed by medication (systolic BP \>160 mmHg or diastolic BP \>97 mmHg) * Currently using study-indicated medications such as those for dyslipidemia or diabetes * On drug treatment with a history of peripheral atherosclerosis and coronary artery disease (peripheral vascular disease, abdominal aortic aneurysm, carotid artery disease) * Coronary artery bypass surgery, vascular anastomosis, pacemaker use, myocardial infarction, heart failure, arrhythmia, or other cardiac disease within 6 months * Infectious inflammatory disease, systemic infection, immune-resistance-related disease, or leukemia (blood cancer) * Irritable bowel syndrome, gastrointestinal resection surgery, or GI-related disease such as Crohn's disease * History of cerebral ischemia or cerebral hemorrhage such as cerebral infarction or stroke due to atherosclerosis * Concurrent symptoms of myocardial infarction, atherosclerosis, or congestive heart failure * Clinically significant liver dysfunction (ALT or AST ≥2.5x the upper limit of normal) * Clinically significant renal dysfunction (serum creatinine \>2.0 mg/dL) * TSH outside 0.27-5.07 microIU/mL or thyroid disease * History of, or current treatment for, psychiatric/neurological disorders including schizophrenia, depression, or drug addiction * History of malignant tumor within 5 years before screening * Pregnant or breastfeeding women, women of childbearing potential not using medically reliable contraception, or women within 6 months postpartum * Alcohol consumption within the last 3 days (men 30 g/day, women 20 g/day) * Participation in another clinical trial within 4 weeks before participation * Subjects judged unsuitable by the investigator or other physicians